Home » Stocks » CLXT

Calyxt, Inc. (CLXT)

Stock Price: $6.07 USD 1.03 (20.34%)
Updated Jan 15, 2021 4:00 PM EST - Market closed
After-hours: $6.22 +0.16 (2.56%) Jan 15, 7:45 PM
Market Cap 208.68M
Revenue (ttm) 13.69M
Net Income (ttm) -43.61M
Shares Out 33.20M
EPS (ttm) -1.32
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day January 15
Last Price $6.07
Previous Close $5.04
Change ($) 1.03
Change (%) 20.34%
Day's Open 5.16
Day's Range 5.12 - 6.19
Day's Volume 708,317
52-Week Range 2.48 - 7.65

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
Business Wire - 1 month ago

ROSEVILLE, Minn.--(BUSINESS WIRE)--Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, announced today that it has contracted to sell all 2020 grain production of its high oleic soy...

Other stocks mentioned: ADM
Seeking Alpha - 1 month ago

Project delays and slower than anticipated growth contradicts CLXT's business model that claim a speedy development cycle using novel gene-editing technologies.

Zacks Investment Research - 1 month ago

Calyxt (CLXT) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Business Wire - 2 months ago

ROSEVILLE, Minn.--(BUSINESS WIRE)--Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, today announced a research collaboration with NRGene® that includes the adoption of NRGene's c...

Seeking Alpha - 2 months ago

Calyxt, Inc.'s (CLXT) CEO Jim Blome on Q3 2020 Results - Earnings Call Transcript

Business Wire - 2 months ago

ROSEVILLE, Minn.--(BUSINESS WIRE)--Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, has reported its financial results for the third quarter ended September 30, 2020. Execution o...

Business Wire - 2 months ago

ROSEVILLE, Minn.--(BUSINESS WIRE)--Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, announced today that it has agreed to commercial terms with S&W Seed Company (Nasdaq: SANW), a...

Other stocks mentioned: SANW
Business Wire - 2 months ago

ROSEVILLE, Minn.--(BUSINESS WIRE)--Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, will host a Virtual Analyst Day on Tuesday, November 17, 2020 at 4:00 p.m. Eastern time. The V...

Business Wire - 2 months ago

ROSEVILLE, Minn.--(BUSINESS WIRE)--Calyxt, Inc. (NASDAQ: CLXT) (the “Company”), a plant-based technology company, today announced the closing of its previously announced registered direct offe...

Business Wire - 2 months ago

ROSEVILLE, Minn.--(BUSINESS WIRE)--Calyxt, Inc. (NASDAQ: CLXT) (the “Company”), a plant-based technology company, today announced that it has entered into definitive agreements with institutio...

Business Wire - 3 months ago

ROSEVILLE, Minn.--(BUSINESS WIRE)--Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, announced today that it has appointed Sarah Reiter as Vice President, Business Development. In...

Business Wire - 3 months ago

ROSEVILLE, Minn.--(BUSINESS WIRE)--Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, will hold a conference call on Thursday, November 5, 2020 at 4:30 p.m. Eastern time to discuss...

Business Wire - 4 months ago

ROSEVILLE, Minn.--(BUSINESS WIRE)--Calyxt, Inc.

Seeking Alpha - 5 months ago

Calyxt, Inc. (CLXT) CEO James Blome on Q2 2020 Results - Earnings Call Transcript

Business Wire - 5 months ago

ROSEVILLE, Minn.--(BUSINESS WIRE)--Calyxt, Inc.

Business Wire - 5 months ago

ROSEVILLE, Minn.--(BUSINESS WIRE)--Calyxt, Inc.

Business Wire - 5 months ago

ROSEVILLE, Minn.--(BUSINESS WIRE)--Calyxt, Inc.

Business Wire - 6 months ago

ROSEVILLE, Minn.--(BUSINESS WIRE)--Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, announced the appointment of current board member Yves Ribeill, Ph.D., as Chairman. This appoi...

Zacks Investment Research - 7 months ago

U.S. consumer confidence gained in May and beat the expectations of economists polled by Dow Jones.

Other stocks mentioned: BGS, INO, MED, PRPL
Zacks Investment Research - 7 months ago

Calyxt (CLXT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Seeking Alpha - 8 months ago

Calyxt's (CLXT) CEO Jim Blome on Q1 2020 Results - Earnings Call Transcript

Seeking Alpha - 10 months ago

Calyxt, Inc.'s (CLXT) CEO Jim Blome on Q4 2019 Results - Earnings Call Transcript

The Motley Fool - 11 months ago

Investors shouldn't forget that the world of biotech extends beyond biopharmaceuticals.

Other stocks mentioned: DTIL, CLLS
GuruFocus - 1 year ago

Falling knives are companies whose share prices have declined more than 59% over the last 52 weeks.

Other stocks mentioned: KSHB
Seeking Alpha - 1 year ago

Calyxt, Inc.'s (CLXT) CEO Jim Blome on Q3 2019 Results - Earnings Call Transcript

Seeking Alpha - 1 year ago

Calyxt, Inc. (CLXT) CEO Jim Blome on Q2 2019 Results - Earnings Call Transcript

Zacks Investment Research - 1 year ago

Calyxt (CLXT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Seeking Alpha - 1 year ago

Calyxt has now commercialized two products from its high-oleic soybean platform and sales should start ramping this year.

Seeking Alpha - 1 year ago

Calyxt, Inc. (CLXT) CEO Jim Blome on Q1 2019 Results - Earnings Call Transcript

Zacks Investment Research - 1 year ago

Calyxt (CLXT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Investment Research - 1 year ago

Calyxt (CLXT) delivered earnings and revenue surprises of -4.00% and -99.83%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?

About CLXT

Calyxt, a technology company, focuses on delivering plant-based solutions in the United States. The company offers high oleic soybean products, including oil and meal. It also develops high fiber wheat; improved digestibility alfalfa; and cold storable potatoes. The company was formerly known as Cellectis Plant Sciences, Inc. and changed its name to Calyxt, Inc. in May 2015. Calyxt, Inc. was founded in 2010 and is headquartered in Roseville, Minnesota. Calyxt, Inc. is a subsidiary of Cellectis S.A.

Industry
Packaged Foods
IPO Date
Jul 20, 2017
CEO
James A. Blome
Employees
75
Stock Exchange
NASDAQ
Ticker Symbol
CLXT
Full Company Profile

Financial Performance

In 2019, Calyxt's revenue was $7.30 million, an increase of 2,991.53% compared to the previous year's $236,000. Losses were -$39.61 million, 42.0% more than in 2018.

Financial Statements

Analyst Forecasts

According to 7 analysts, the average rating for Calyxt stock is "Buy." The 12-month stock price forecast is 7.13, which is an increase of 17.56% from the latest price.

Price Target
$7.13
(17.56% upside)
Analyst Consensus: Buy